首页> 外文期刊>Nucleic Acids Research >TARGET SEQUENCE-SPECIFIC INHIBITION OF HIV-1 REPLICATION BY RIBOZYMES DIRECTED TO TAT RNA
【24h】

TARGET SEQUENCE-SPECIFIC INHIBITION OF HIV-1 REPLICATION BY RIBOZYMES DIRECTED TO TAT RNA

机译:靶向TAT RNA的核酶对HIV-1复制的靶序列特异性抑制

获取原文
获取原文并翻译 | 示例
           

摘要

The structural motif formed between a hammerhead ribozyme and its substrate consists of three RNA double helices in which the sequence 5' to the XUY is termed helix I and the sequence 3' to the XUY helix III. Two hammerhead ribozymes targeted to the tat gene of HIV-1SF2 were designed to study target specificity and the potential effect of helix I mismatch on ribozyme efficacy both in vitro and in vivo. The first ribozyme (Rz1) targeted to the 5' splicing region of the tat gene was designed to cleave GUC*A. In HIV-1IIIB the A is changed to a G. The second ribozyme (Rz2) was targeted to the translational initiation region of the tat gene which is highly conserved among a variety of HIV-1 isolates, including both HIV-1SF2 and HIV-1IIIB. In vitro cleavage studies demonstrated that Rz1 efficiently cleaved HIV-1SF2 substrate RNA, but not HIV-1IIIB, presumably due to the base change from A to G. In contrast, Rz2 cleaved HIV-1SF2 or HIV-1IIIB substrate with equal efficiency. Both ribozymes were cloned into the 3' untranslated region of the neomycin gene (neo) within the pSV2neo vector and transfected into the SupT1 human CD4(+) T cell line. Following selection, stable transfectants were challenged with either HIV-1SF2 or HIV-1IIIB virus. While Rz1-expressing cells were significantly protected from HIV-1SF2 infection, they exhibited no protection when infected with HIV-1IIIB virus. In contrast, Rz2 was effective in inhibiting the replication of both HIV-1SF2 and HIV-1IIIB in SupT1 cells. Expression of both ribozymes in these cells was demonstrated by Northern analysis, RT-PCR sequencing analysis confirmed the respective HIV-1 target sequence integrity. These data demonstrate the importance of the first base pair distal to the XUY within helix I of the hammerhead structure for both in vitro and in vivo ribozyme activities and imply that the effectiveness of the anti-HIV-1 ribozymes against appropriate target sequences is due to their catalytic activities rather than any antisense effect.
机译:锤头状核酶和其底物之间形成的结构基序由三个RNA双螺旋组成,其中XUY的5'序列称为I螺旋,XUY螺旋III的序列3'。设计了两种靶向HIV-1SF2的tat基因的锤头状核酶,以研究靶标特异性以及螺旋I错配对体内外核酶功效的潜在影响。靶向tat基因5'剪接区的第一个核酶(Rz1)被设计为切割GUC * A。在HIV-1IIIB中,A变为G。第二个核酶(Rz2)靶向tat基因的翻译起始区域,该基因在包括HIV-1SF2和HIV- 1IIIB。体外裂解研究表明,Rz1有效裂解了HIV-1SF2底物RNA,但未裂解HIV-1IIIB,大概是由于碱基从A变为G。相反,Rz2有效裂解了HIV-1SF2或HIV-1IIIB底物。将两个核酶克隆到pSV2neo载体内新霉素基因(neo)的3'非翻译区中,并转染到SupT1人CD4(+)T细胞系中。选择后,稳定的转染子用HIV-1SF2或HIV-1IIIB病毒攻击。尽管表达Rz1的细胞受到了HIV-1SF2感染的显着保护,但是当感染HIV-1IIIB病毒时它们却没有表现出任何保护作用。相反,Rz2有效抑制SupT1细胞中HIV-1SF2和HIV-1IIIB的复制。通过Northern分析证实了两种核酶在这些细胞中的表达,RT-PCR测序分析证实了各自HIV-1靶序列的完整性。这些数据证明了锤头结构螺旋I中XUY远端的第一个碱基对对于体内和体外核酶活性的重要性,并暗示抗HIV-1核酶针对适当靶序列的有效性是由于它们的催化活性,而不是任何反义作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号